|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Preparation of highly efficient manganese catalase mimics显示文摘 | Triller M U Hsieh W Y Pecoraro V L | 2002 | Inorg Chem2002，41，： | 1 |
| 2 | Fluoride as preventive agent of caries:mechanisms,sourees,risks显示文摘 | Triller M | 1998 | Archives de Pediatrie1998，5，10： | 1 |
| 3 | Fluoride as preventive agent of caries: mechanisms,sources, risks 显示文摘 | Triller M | 1998 | Archives de Pediatrie1998，5，10： | 1 |
| 4 | Exenatide : a new option for the treatment of type 2 diabetes 显示文摘 | Yoo B K Triller D M Yoo D J | 2006 | Ann Pharmacother2006，40，： | 1 |
| 5 | Prospective molecular marker analyses of EGFR and KRAS from a randomized,placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer显示文摘 | Brugger W Triller N Blasinska-Morawiec M | | 0，，31： | 1 |
| 6 | Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clini- cal setting显示文摘 | Lekic M Kovac V Triller N | 2012 | Radiol Oncol2012，46，： | 1 |
| 7 | Biomarker analyses from the phase Ⅲ placebo-controlled SATURN study of maintenance erlotinib following first-line chemotherapy for advanced NSCLC显示文摘 | Brugger W Triller N Blasinska-Morawiec M | | 0，，8020： | 1 |
| 8 | α-2,8-Polysialic acid is the neuronal surface receptor of antennapedia homeobox peptide显示文摘 | Joliot A Triller A Volovitch M | | 0，，11： | 1 |
| 9 | Prospective molecular marker analyses of EGFR and KRAS from a randomized,placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer显示文摘 | Brugger W Triller N Blasinska-Morawiec M | | 0，，31： | 1 |
| 10 | Effcient Sensor Placement for On- Orbit Modal Identification of Se-quentially Assembled Large Space Structures 显示文摘 | Kammer D C Triller M J | 1992 | The International Journal of Analytical and Experimental Modal Analysis1992，7，2： | 1 |
| 11 | Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer 显示文摘 | BRUGGER W TRILLER N BLASIBSKA-MORAWIEC M | 2011 | J Clin Oncol2011，29，31： | 1 |
| 12 | Labeling neuronal membrane receptors with quantum dots显示文摘 | Lévi S Dahan M Triller A | 2011 | Cold Spring Harbor Protocols2011，2011，3： | 1 |
| 13 | Molecular dynamics of postsynaptic re- ceptors and scaffold proteins显示文摘 | Renner M Specht CG Triller A | 2008 | Cnrr Opin Neurobiol2008，18，5： | 1 |
| 14 | Otoferlin,defective in a human deaf-ness form,is essential for exocytosis at the auditory ribbon syn-apse显示文摘 | Roux I Safieddine S Nouvian R Grati M Simmler M-C Bahloul A Perfettini I Le Gall M Rostaing P Hamard G Triller A Avan P Moser T Petit C | | 0，，： | 1 |
| 15 | Epithelioid hemangioendothelioma of the liv- er: a rare hepatic tumor显示文摘 | Lauffer J M Zimmermann A Krahenbtihl L Triller J Baer H U | 1996 | Cancer1996，78，： | 1 |
| 16 | Prospective molecular marker analyses of EGFR and KRAS from a random- ized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small cell lung cancer显示文摘 | Brugger W Triller N Blasinska-Morawiec M | 2011 | j ClinOncol2011，29，31： | 1 |
| 17 | Risk of adverse drug events by patient destination after hospital discharge显示文摘 | Clause S L Hamilton B A | 2005 | Am J Health-Syst Pharm2005，62，18： | 1 |
| 18 | Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer显示文摘 | Brugger W Triller N Blasinska-Morawiec M | 2011 | J Clin Oncol2011，29，31： | 1 |
| 19 | Prospec- tive molecular marker analyses of EGFR and KRAS from a randomized,placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer显示文摘 | Brugger W Triller N Blasinska-Morawiec M | 2011 | J Clin On- col2011，29，31： | 1 |
| 20 | Prospective molecular marker analyses of EGFR and KRAS from a randomized,placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer显示文摘 | BRUGGER W TRILLER N BLASINSKA-MORAWIEC M | | 0，，31： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员